Abstract
AbstractBreast Cancer Metastasis Suppressor 1 (BRMS1) expression is associated with longer patient survival in multiple cancer types. Understanding BRMS1 functionality will provide insights into both mechanism of action and will enhance potential therapeutic development. In this study, we confirmed that the C-terminus of BRMS1 is critical for metastasis suppression and hypothesized that critical protein interactions in this region would explain its function. Phosphorylation status at S237 regulates BRMS1 protein interactions related to a variety of biological processes, phenotypes [cell cycle (e.g., CDKN2A), DNA repair (e.g., BRCA1)], and metastasis [(e.g., TCF2 and POLE2)]. Presence of S237 also directly decreased MDA-MB-231 breast carcinoma migration in vitro and metastases in vivo. The results add significantly to our understanding of how BRMS1 interactions with Sin3/HDAC complexes regulate metastasis and expand insights into BRMS1’s molecular role, as they demonstrate that BRMS1 C-terminus involvement in distinct direct protein-protein interactions.
Publisher
Cold Spring Harbor Laboratory
Reference61 articles.
1. Defining the Hallmarks of Metastasis
2. Y. Liu , M.W. Mayo , A. Xiao , E.H. Hall , E.B. Amin , K. Kadota , P.S. Adusumilli , D.R. Jones , Loss of BRMS1 Promotes a Mesenchymal Phenotype through NF-kappaB-Dependent Regulation of Twist1, Mol. Cell Biol, (2014).
3. Metastasis suppressor genes: Basic biology and potential clinical use, Clin;Breast Cancer,2003
4. Microenvironmental Influences on Metastasis Suppressor Expression and Function during a Metastatic Cell’s Journey;Cancer Microenviron.,2014
5. Functional evidence for a novel human breast carcinoma metastasis suppressor, BRMS1, encoded at chromosome 11q13;Cancer Res.,2000